Cargando…
Association of Subclinical Hypothyroidism With Anxiety Symptom in Young First-Episode and Drug-Naïve Patients With Major Depressive Disorder
BACKGROUNDS: Subclinical hypothyroidism (SCH) was reported to be associated with depression; however, its role in coexisting anxiety symptom in young patients with major depressive disorder (MDD) remains unclear. The objective of this study was to explore the relationship between SCH and anxiety sym...
Autores principales: | Yang, Ruchang, Du, Xiangdong, Li, Zhe, Zhao, Xueli, Lyu, Xiaoli, Ye, Gang, Lu, Xinchuan, Zhang, Guangya, Li, Chuanwei, Yue, Yan, Wu, Yuxuan, Peng, Ruijie, Zhou, Yue, Wang, Haitao, Wu, Siqi, Ganapathi, Pallavi B., Wu, Hanjing Emily, Zhang, Xiangyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263214/ https://www.ncbi.nlm.nih.gov/pubmed/35815037 http://dx.doi.org/10.3389/fpsyt.2022.920723 |
Ejemplares similares
-
Suicide attempt rate and the risk factors in young, first-episode and drug-naïve Chinese Han patients with major depressive disorder
por: Ye, Gang, et al.
Publicado: (2022) -
Sex-differential association of suicide attempts with thyroid dysfunction in first-episode and drug-naïve young major depressive disorder patients with comorbid anxiety
por: Ye, Gang, et al.
Publicado: (2023) -
Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia
por: Wu, Yuxuan, et al.
Publicado: (2022) -
Prevalence and clinical correlates of psychotic symptoms in first-episode untreated female chinese patients with major depressive disorder
por: Peng, Ruijie, et al.
Publicado: (2023) -
Efficacy and safety of Transcranial Direct Current Stimulation (tDCS) on cognitive function in chronic schizophrenia with Tardive Dyskinesia (TD): a randomized, double-blind, sham-controlled, clinical trial
por: Zhou, Yue, et al.
Publicado: (2023)